4-(2-{[(Methylsulfonyl)amino]carbonyl}-8-{[4-(4-phenylbutoxy)benzoyl]amino}-2,3-dihydro-4H-1,4-benzoxazin-4-yl)butanoic acid

ID: ALA3401690

Chembl Id: CHEMBL3401690

PubChem CID: 11227280

Max Phase: Preclinical

Molecular Formula: C31H35N3O8S

Molecular Weight: 609.70

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)NC(=O)C1CN(CCCC(=O)O)c2cccc(NC(=O)c3ccc(OCCCCc4ccccc4)cc3)c2O1

Standard InChI:  InChI=1S/C31H35N3O8S/c1-43(39,40)33-31(38)27-21-34(19-8-14-28(35)36)26-13-7-12-25(29(26)42-27)32-30(37)23-15-17-24(18-16-23)41-20-6-5-11-22-9-3-2-4-10-22/h2-4,7,9-10,12-13,15-18,27H,5-6,8,11,14,19-21H2,1H3,(H,32,37)(H,33,38)(H,35,36)

Standard InChI Key:  XFDWMOIFWMJDPH-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3401690

   4-[2-(Methylsulfonylcarbamoyl)-8-[[4-(4-phenylbutoxy)benzoyl]amino]-2,3-dihydro-1,4-benzoxazin-4-yl]butanoic acid

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 609.70

Molecular Weight (Monoisotopic): 609.2145

AlogP: 3.85

#Rotatable Bonds: 14

Polar Surface Area: 151.34

Molecular Species: ACID

HBA: 8

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 3.46

CX Basic pKa: 1.18

CX LogP: 3.96

CX LogD: -0.28

Aromatic Rings: 3

Heavy Atoms: 43

QED Weighted: 0.23

Np Likeness Score: -0.69

References

1. Itadani S, Takahashi S, Ima M, Sekiguchi T, Aratani Y, Egashira H, Matsumura N, Inoue A, Yonetomi Y, Fujita M, Nakayama Y, Takeuchi J..  (2015)  Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acid.,  23  (9): [PMID:25800431] [10.1016/j.bmc.2015.03.011]

Source

Source(1):

• Scientific Literature